Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Tumor necrosis factor alpha and breast cancer (CROSBI ID 119867)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Sirotković-Skerlev, Maja ; Čačev, Tamara ; Kapitanović, Sanja Tumor necrosis factor alpha and breast cancer // Periodicum biologorum, 108 (2006), 5; 541-546

Podaci o odgovornosti

Sirotković-Skerlev, Maja ; Čačev, Tamara ; Kapitanović, Sanja

engleski

Tumor necrosis factor alpha and breast cancer

A large number of studies suggest that beside tumor autonomous abnormalities, tumor-microenvironment interactions may affect tumor growth and metastasis formation. Inflammatory cells, primarily macrophages may affect tumor development and progression by their ability to express a large variety of factors, including inflammatory cytokines. One of these cytokines is tumor necrosis factor alpha (TNFalpha ). TNFalpha is a primary mediator in the pathogenesis of infection, injury and inflammation. It is involved in the beneficial processes of host defense and tissue homeostasis. The net biological effects of TNFalpha may ultimately benefit or injure the host, depending on its concentration, duration of tissue exposure and the presence of other mediators in the cellular environment. TNFalpha may exert anti-tumor and protumor activity. These effects have been examined in various experimental models and in different clinical settings. In this article we discuss the anti-tumor and protumor activities of TNFalpha with a special reference to breast cancer.

TNF alpha ; breast cancer

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

108 (5)

2006.

541-546

objavljeno

0031-5362

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost